| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |